SITAGLIPTINE/METFORMINE EVOLUGEN 50 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 60 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930254325
  • CIP7 3025432
  • CIS 60913329

What the source publishes

Holder
EVOLUPHARM
Active ingredients
SITAGLIPTINE, CHLORHYDRATE DE METFORMINE, CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ
Form
comprimé pelliculé
Package
plaquette(s) PVC polyéthylène PVDC aluminium de 60 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2022-06-13
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930254325
{
  "cis": "60913329",
  "cip7": "3025432",
  "form": "comprimé pelliculé",
  "name": "SITAGLIPTINE/METFORMINE EVOLUGEN 50 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC polyéthylène PVDC aluminium de 60 comprimé(s)",
  "cip13": "3400930254325",
  "holder": "EVOLUPHARM",
  "routes": [
    "orale"
  ],
  "holders": [
    "EVOLUPHARM"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "9.64",
  "authorisedOn": "2022-06-13",
  "compositions": [
    {
      "name": "SITAGLIPTINE",
      "nature": "FT",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "20740",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE METFORMINE",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "2",
      "substanceCode": "24321",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "85939",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "8.62",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SITAGLIPTINE/METFORMINE EVOLUGEN 50 mg/1000 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) PVC polyéthylène PVDC aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2025-09-26",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SITAGLIPTINE",
    "CHLORHYDRATE DE METFORMINE",
    "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930254325"